Evidence must remain inspectable
Every conclusion should connect back to the papers, trials and observations that support it.
Helix Research Intelligence
Shortening the path from biomedical discovery to therapeutic development
Helix Research Intelligence builds scientific intelligence infrastructure for translational research teams. Our mission is to help researchers turn fragmented biomedical evidence into decisions they can understand, verify and carry forward.
- 1Discovery
- 2Evidence
- 3Decision
- 4Therapy
The problem
Biomedical research produces more knowledge than teams can effectively use
Scientific evidence lives across publications, clinical trial registries, patents, internal documents and individual expertise.
Researchers repeatedly reconstruct context, compare conflicting findings and retrace decisions their organization has already made. Valuable knowledge disappears between projects, tools and people.
The result is slower research, duplicated effort and decisions made without the full scientific context.
Our mission
Transform biomedical research into an intelligence-augmented decision system
We are building the infrastructure that connects scientific discovery, translational reasoning and therapeutic development. Every important decision should preserve its evidence, assumptions, contradictions and context.
Better scientific memory leads to better scientific decisions.
Our principles
What we believe
Context should compound
Decisions, rejected hypotheses and unresolved questions should remain useful across people and projects.
AI should support scientific judgment
AI can accelerate synthesis and reveal connections. Researchers remain responsible for interpretation and decisions.
Research software should fit the workflow
Technology creates value when it reduces repeated work and helps teams decide what to investigate next.
Atlas
A scientific intelligence workspace for translational teams
Atlas is the first product built by Helix Research Intelligence. It connects scientific literature, clinical trials, patents and project knowledge around each therapeutic program.
Explore Atlas- Build the evidence baseIdentify relevant public scientific and clinical sources.
- Connect the findingsOrganize evidence around diseases, targets, biomarkers, molecules and trials.
- Preserve the reasoningKeep important findings, hypotheses and decisions in the project's memory.
- Advance the programUse that context to prioritize questions, experiments and development work.
Who we serve
Built for teams translating science into therapies
Atlas is designed for biotech and pharmaceutical research teams working across discovery, translational research and early development. We initially focus on emerging biotech companies, where small scientific teams must evaluate large bodies of evidence and make consequential decisions with limited time and resources.
The company
Helix Research Intelligence
Helix Research Intelligence is a French technology company developing scientific intelligence infrastructure for biomedical research. The company builds Atlas for translational teams seeking a more rigorous, connected and durable way to use scientific evidence.
- Legal form
- SASU with share capital of €10,000
- Registration
- RCS Nanterre — SIREN 107 351 702
- Registered office
- 50 rue Colbert, 92700 Colombes, France
- Founded
- 7 July 2026
- Publication director
- Julien Jouhault
The next therapy may depend on a decision being made today
We are building Atlas to give research teams the evidence, context and scientific memory behind that decision.